- TOP
- Publications
- Legal Affairs for Chinese Life Sciences and Healthcare (Part 2) –Approaching the implementation of China GVP (Good Pharmacovigilance Practice) (effective from December 1, 2021) (1)
Legal Affairs for Chinese Life Sciences and Healthcare (Part 2) –Approaching the implementation of China GVP (Good Pharmacovigilance Practice) (effective from December 1, 2021) (1)
Authors:
Fumi Takatsuki
Latest China Law Newsletter Volume. 2
Publisher:Oh-Ebashi LPC & Partners
Practice: Research and Development Cosmetics & Health/Beauty Care Products Chinese Practice
Date of publication: September 30, 2021
Other publications by Fumi Takatsuki
- 2023.02.27
- China’s Life Science and Healthcare-No.3 Amendment of the Regulations on Cosmetics in China
- 2022.03.14
- A Legal Review of China’s Life Sciences and 2 Healthcare- No.1 -General Introduction and MAH System
- 2017.12.27
- 100 Selected Cases in China, Series 250
Other publications about Research and Development
Other publications about Chinese Practice
- 2024.04.24
- Restructuring and Withdrawal of Chinese Subsidiaries (5)- Withdrawal (i) Share Assingment
- 2023.09.29
- [Report from China] Playing Golf in China
- 2023.04.26
- [Report from China] Chat GPT and China
- 2023.02.27
- China’s Life Science and Healthcare-No.3 Amendment of the Regulations on Cosmetics in China
- 2023.01.20
- [Report from China] Traveling to China Immediately after the Lifting of the “Zero-Covid” Policy
- 2022.11.29
- [Report from China] My Experience When China’s Health Code System Indicated a Yellow Code
- 2022.08.22
- Summary of the Amendment to the Chinese Anti-Monopoly Law (1) – Combination of business operators
- 2022.03.14
- A Legal Review of China’s Life Sciences and 2 Healthcare- No.1 -General Introduction and MAH System
- 2019.03.22
- Building a Compliance System for China-based Affiliates – Mainly on the Aspects of Transactions
- 2017.12.27
- 100 Selected Cases in China, Series 250
- 2017.02.01
- Chinese Business Law System
- 2017.02.01
- Chinese Business Law System: Organized by Internal Division and by Situation [Second Edition]
- 2015.02.01
- Supreme People's Court decision on Abuse of Market Dominant Position under China’s Antitrust Law
- 2009.04.01
- Withdrawal by Transfer of Equity Interest